Skip to main content
MEDICOX Co., Ltd. logo

MEDICOX Co., Ltd. — Investor Relations & Filings

Ticker · 054180 ISIN · KR7054180005 KO Manufacturing
Open in API
Filings indexed 803 across all filing types
Latest filing 2021-06-03 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 054180

About MEDICOX Co., Ltd.

https://www.medicox.co.kr

MEDICOX Co., Ltd., formerly ChoongAng Ocean Co Ltd, is a company engaged in the manufacture and sale of shipbuilding materials and equipment. Its primary products are structural components for large vessels, including curved blocks, bow and stern sections, propeller bosses, and engine room parts. In addition to its core shipbuilding business, the company is diversifying into the biopharmaceutical sector, focusing on new drug development and the commercialization of pharmaceutical products.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Major Report' (주요사항보고서) concerning the issuance of convertible bonds (전환사채권 발행결정). It details specific corrections to the terms of the bonds, such as call options, put options, and collateral information. In the context of Korean regulatory filings (DART), this is a standard amendment to a capital-raising disclosure. Since it is a formal regulatory filing detailing changes to a financial instrument issuance, it falls under the 'Regulatory Filings' category as a fallback for specific corporate disclosures that do not fit into other categories like 10-K or ER.
2021-06-03 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange, specifically detailing the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). It contains detailed terms of the bond issuance, including interest rates, conversion prices, call/put options, and use of proceeds. This type of regulatory filing regarding capital structure and financing activities is classified as a Capital/Financing Update.
2021-06-02 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for the company 'Medicox'. It details the agenda items, including the appointment of directors and the addition of business purposes to the articles of incorporation. This type of document, which provides information to shareholders regarding upcoming meetings and the items to be voted upon, is classified as a Proxy Solicitation & Information Statement (PSI).
2021-05-25 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) for Medicox Co., Ltd. It contains the meeting agenda, details on board member elections, and management reference materials (경영참고사항) including business overviews, industry status, and financial information. This type of document is standard for proxy solicitation and shareholder information, which falls under the Proxy Solicitation & Information Statement category.
2021-05-25 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by a company to solicit proxies from shareholders for an upcoming general meeting. This document provides information about the meeting agenda, director candidates, and voting procedures. It falls under the 'Proxy Solicitation & Information Statement' category.
2021-05-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when directors or major shareholders change their equity holdings. This type of filing is classified as a 'Director's Dealing' (DIRS) report, as it details the acquisition of shares by a major shareholder (Mecox Biomed) in the issuing company (Medicox).
2021-05-21 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.